Match unrelated bone marrow transplantation in a case of high risk myelodysplastic syndrome treated with azacitidine and concomitant 1alpha-25-dihydroxyvitamin D3, as differentiating agent.
Orciuolo
Enrico
E
Cecconi
Nadia
N
Galimberti
Sara
S
Papineschi
Federico
F
Petrini
Mario
M
D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D001374:Azacitidine / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D002454:Cell Differentiation / Q000187:drug effects*; D005260:Female; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000628:therapy*; D014807:Vitamin D / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000964:Antimetabolites, Antineoplastic; C118756:dihydroxy-vitamin D3; D014807:Vitamin D; D001374:Azacitidine